Koyfin Home > Directory > Health Care > Horizon Therapeutics > Net Income

Horizon Therapeutics Net Income Chart (HZNP)

Horizon Therapeutics annual/quarterly Net Income from 2010 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Horizon Therapeutics Net Income for the quarter ending September 09, 2020 was $293m a -102.42% decrease of -300m year over year
  • Horizon Therapeutics Net Income for the last 12 months ending September 09, 2020 was $792m a 27.65% increase of 219m year over year
  • Horizon Therapeutics Annual Net Income for 2019 was $573m a 106.70% increase of 611m from 2018
  • Horizon Therapeutics Annual Net Income for 2018 was $-38m a -812.26% increase of 312m from 2017
  • Horizon Therapeutics Annual Net Income for 2017 was $-350m a 52.71% decrease of -185m from 2016
Other Income Statement Metrics:
  • Horizon Therapeutics EBITDA for the quarter ending December 12, 2018 was $54m a 229.73% increase of 125m year over year
  • Horizon Therapeutics Total Revenue for the quarter ending December 12, 2018 was $356m a 37.03% increase of 132m year over year
View Chart On Koyfin

Quarterly HZNP Net Income Data

09/2020$293m
06/2020$-80m
03/2020$-14m
12/2019$593m
09/2019$18m
06/2019$-5m
03/2019$-33m
12/2018$102m
09/2018$33m
06/2018$-25m

Annual HZNP Net Income Data

2019$573m
2018$-38m
2017$-350m
2016$-166m
2015$40m
2014$-264m
2013$-149m
2012$-88m
2011$-113m
2010$-27m